Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic deep brain stimulation

Parkinsonism and Related Disorders

Volumn 14, Issue 2, 2008, Pages 114-119

  Wider, C ^a   Pollo, C ^a   Bloch, J ^a   Burkhard, P R ^b   Vingerhoets, F J G ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b HUG   (Switzerland)

Author keywords

Deep brain stimulation; Outcome; Parkinson disease; Subthalamic nucleus; Surgical treatment

Indexed keywords

ANTIBIOTIC AGENT; CARBIDOPA PLUS LEVODOPA; ANTIPARKINSON AGENT;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DYSKINESIA; FEMALE; FOLLOW UP; HUMAN; MALE; MORTALITY; PARKINSON DISEASE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME; COHORT ANALYSIS; ELECTRODE; MICROELECTRODE; MIDDLE AGED; MOVEMENT (PHYSIOLOGY); NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; PROSPECTIVE STUDY; STEREOTACTIC PROCEDURE; SURVIVAL;

AGED; ANTIPARKINSON AGENTS; COHORT STUDIES; DEEP BRAIN STIMULATION; ELECTRODES, IMPLANTED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICROELECTRODES; MIDDLE AGED; MOVEMENT; PARKINSON DISEASE; PROSPECTIVE STUDIES; STEREOTAXIC TECHNIQUES; SUBTHALAMIC NUCLEUS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 43649108353     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2007.06.012     Document Type: Article

References (38)

1. Limousin P., Pollak P., Benazzouz A., Hoffmann D., Le Bas J.F., Broussolle E., et al. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 345 8942 (1995) 91-95
2. Krack P., Pollak P., Limousin P., Benazzouz A., and Benabid A.L. Stimulation of subthalamic nucleus alleviates tremor in Parkinson's disease. Lancet 350 9092 (1997) 1675
3. Limousin P., Krack P., Pollak P., Benazzouz A., Ardouin C., Hoffmann D., et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 339 16 (1998) 1105-1111
4. Kumar R., Lozano A.M., Kim Y.J., Hutchison W.D., Sime E., Halket E., et al. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology 51 3 (1998) 850-855
5. Moro E., Scerrati M., Romito L.M., Roselli R., Tonali P., and Albanese A. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology 53 1 (1999) 85-90
6. Vingerhoets F.J., Villemure J.G., Temperli P., Pollo C., Pralong E., and Ghika J. Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up. Neurology 58 3 (2002) 396-401
7. The Deep-Brain Stimulation for Parkinson's Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 345 13 (2001) 956-963
8. Krack P., Batir A., Van B.N., Chabardes S., Fraix V., Ardouin C., et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 349 20 (2003) 1925-1934
9. Schupbach W.M., Chastan N., Welter M.L., Houeto J.L., Mesnage V., Bonnet A.M., et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry 76 12 (2005) 1640-1644
10. Visser-Vandewalle V., van der L.C., Temel Y., Celik H., Ackermans L., Spincemaille G., et al. Long-term effects of bilateral subthalamic nucleus stimulation in advanced Parkinson disease: a four year follow-up study. Parkinsonism Relat Disord 11 3 (2005) 157-165
11. Rodriguez-Oroz M.C., Obeso J.A., Lang A.E., Houeto J.L., Pollak P., Rehncrona S., et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 128 Pt 10 (2005) 2240-2249
12. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55 3 (1992) 181-184
13. Langston J.W., Widner H., Goetz C.G., Brooks D., Fahn S., Freeman T., et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 7 1 (1992) 2-13
14. Pollo C., Vingerhoets F., Pralong E., Ghika J., Maeder P., Meuli R., et al. Localization of electrodes in the subthalamic nucleus on magnetic resonance imaging. J Neurosurg 106 (2007) 36-44
15. Russmann H., Ghika J., Villemure J.G., Robert B., Bogousslavsky J., Burkhard P.R., et al. Subthalamic nucleus deep brain stimulation in Parkinson disease patients over age 70 years. Neurology 63 10 (2004) 1952-1954
16. Russmann H., Ghika J., Combrement P., Villemure J.G., Bogousslavsky J., Burkhard P.R., et al. l-Dopa-induced dyskinesia improvement after STN-DBS depends upon medication reduction. Neurology 63 1 (2004) 153-155
17. Ostergaard K., and Aa S.N. Evolution of Parkinson's disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus. Mov Disord 21 5 (2006) 624-631
18. Rodriguez M.C., Obeso J.A., and Olanow C.W. Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection. Ann Neurol 44 3 Suppl 1 (1998) S175-S188
19. Louis E.D., Tang M.X., Cote L., Alfaro B., Mejia H., and Marder K. Progression of parkinsonian signs in Parkinson disease. Arch Neurol 56 3 (1999) 334-337
20. Jankovic J., and Kapadia A.S. Functional decline in Parkinson disease. Arch Neurol 58 10 (2001) 1611-1615
21. Olanow C.W., Hauser R.A., Gauger L., Malapira T., Koller W., Hubble J., et al. The effect of deprenyl and levodopa on the progression of Parkinson's disease. Ann Neurol 38 5 (1995) 771-777
22. Hilker R., Portman A.T., Voges J., Staal M.J., Burghaus L., van L.T., et al. Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation. J Neurol Neurosurg Psychiatry 76 9 (2005) 1217-1221
23. Vingerhoets F.J., Snow B.J., Lee C.S., Schulzer M., Mak E., and Calne D.B. Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism. Ann Neurol 36 5 (1994) 759-764
24. Bonnet A.M., Loria Y., Saint-Hilaire M.H., Lhermitte F., and Agid Y. Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions?. Neurology 37 9 (1987) 1539-1542
25. Lang A.E., and Obeso J.A. Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol 3 5 (2004) 309-316
26. Elbaz A., Bower J.H., Peterson B.J., Maraganore D.M., McDonnell S.K., Ahlskog J.E., et al. Survival study of Parkinson disease in Olmsted County, Minnesota. Arch Neurol 60 1 (2003) 91-96
27. Uitti R.J., Ahlskog J.E., Maraganore D.M., Muenter M.D., Atkinson E.J., Cha R.H., et al. Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project. Neurology 43 10 (1993) 1918-1926
28. Burkhard P.R., Vingerhoets F.J., Berney A., Bogousslavsky J., Villemure J.G., and Ghika J. Suicide after successful deep brain stimulation for movement disorders. Neurology 63 11 (2004) 2170-2172
29. Beyer M.K., Herlofson K., Arsland D., and Larsen J.P. Causes of death in a community-based study of Parkinson's disease. Acta Neurol Scand 103 1 (2001) 7-11
30. Hely M.A., Morris J.G., Traficante R., Reid W.G., O'Sullivan D.J., and Williamson P.M. The Sydney multicentre study of Parkinson's disease: progression and mortality at 10 years. J Neurol Neurosurg Psychiatry 67 3 (1999) 300-307
31. Lyons K.E., Wilkinson S.B., Overman J., and Pahwa R. Surgical and hardware complications of subthalamic stimulation: a series of 160 procedures. Neurology 63 4 (2004) 612-616
32. Pilitsis J.G., Rezai A.R., Boulis N.M., Henderson J.M., Busch R.M., and Kubu C.S. A preliminary study of transient confusional states following bilateral subthalamic stimulation for Parkinson's disease. Stereotact Funct Neurosurg 83 2-3 (2005) 67-70
33. Pressley J.C., Louis E.D., Tang M.X., Cote L., Cohen P.D., Glied S., et al. The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology 60 1 (2003) 87-93
34. Bodenmann P., Ghika J., Van M.G., and Bogousslavsky J. Neurological comorbidity in parkinsonism. Rev Neurol (Paris) 157 1 (2001) 45-54
35. Bloem B.R., Grimbergen Y.A., Cramer M., Willemsen M., and Zwinderman A.H. Prospective assessment of falls in Parkinson's disease. J Neurol 248 11 (2001) 950-958
36. Berney A., Vingerhoets F., Perrin A., Guex P., Villemure J.G., Burkhard P.R., et al. Effect on mood of subthalamic DBS for Parkinson's disease: a consecutive series of 24 patients. Neurology 59 9 (2002) 1427-1429
37. Funkiewiez A., Ardouin C., Caputo E., Krack P., Fraix V., Klinger H., et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry 75 6 (2004) 834-839
38. Aybek S, Gronchi-Perrin A, Berney A, Chiuve SC, Villemure JG, Burhhard PR, et al. Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson's disease. Mov Disord 2007 April 18 [Epub ahead of print].